Physician profile
Katherine E Smith
NPI 1568627495
$497.21
in general payments reported to CMS, 2019-2025
13 companies · $147 in 2025
The $147 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.95 · 2020: $15.09 · 2022: $51.97 · 2023: $64.31 · 2024: $178 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $71.46 | 2024-2025 | |
| Cranial Technologies, INC | $60.08 | 2019-2023 | Doc Band |
| Ironshore Pharmaceuticals INC. | $58.69 | 2020-2024 | |
| Pfizer INC. | $50.15 | 2019-2025 | |
| Sanofi Pasteur INC. | $45.01 | 2024-2025 | |
| Abbvie INC. | $36.10 | 2022 | |
| Merck Sharp & Dohme LLC | $33.77 | 2022-2024 | Gardasil 9, Vaxelis, Gardasil |
| Neos Therapeutics, Lp | $28.08 | 2019-2025 | Cotempla Xr-Odt |
| Ultragenyx Pharmaceutical INC. | $27.19 | 2024 | Crysvita |
| Acadia Pharmaceuticals INC | $26.26 | 2024 | Daybue |
| Corium, LLC | $25.13 | 2025 | Azstarys |
| Seqirus USA INC | $18.77 | 2025 | Flucelvax |
| Alk-Abello, INC | $16.52 | 2024 | Grastek, Ragwitek, Odactra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.